Physician profile
Thomas Clark Keller
NPI 1073587515
$18,018.29
in general payments reported to CMS, 2019-2025
61 companies · $2,892 in 2025
The $2,892 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,819 · 2020: $1,962 · 2021: $2,576 · 2022: $3,575 · 2023: $2,572 · 2024: $2,623 · 2025: $2,892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,982 · Education: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,982.34 |
| Education | $104.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,910.07 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,755.18 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $1,376.71 | 2019-2025 | |
| Abbvie INC. | $1,331.19 | 2020-2025 | |
| Summit Surgical Corp. | $1,200.00 | 2022 | |
| Lilly USA, LLC | $983.58 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $910.90 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $698.00 | 2019-2025 | Veozah, Myrbetriq |
| Amarin Pharma, INC. | $548.72 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $502.93 | 2019-2025 | Jardiance, Stiolto Respimat |
| Novartis Pharmaceuticals Corporation | $455.57 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $376.79 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Mannkind Corporation | $327.02 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $326.41 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $272.76 | 2019-2024 | Xarelto |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $240.67 | 2019-2023 | Otezla, Repatha |
| Allergan, INC. | $201.71 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $199.98 | 2022-2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $197.11 | 2019-2025 | Eliquis |
| Exact Sciences Corporation | $196.29 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $195.11 | 2019-2025 | Xifaxan, Trulance |
| Sanofi-Aventis U.S. LLC | $190.21 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $185.10 | 2019-2025 | Trintellix |
| Axsome Therapeutics, INC. | $179.29 | 2023-2025 | Auvelity, Sunosi |
| Teva Pharmaceuticals USA, INC. | $146.99 | 2020-2025 | Austedo Xr, Austedo Xr |
| Lundbeck LLC | $140.07 | 2021-2025 | Rexulti |
| Dexcom, INC. | $131.03 | 2021-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $126.88 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Daiichi Sankyo INC. | $125.46 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $124.94 | 2024-2025 | Voquezna |
| Aimmune Therapeutics, INC. | $123.37 | 2024-2025 | Zenpep |
| Biogen, INC. | $112.43 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $94.47 | 2022 | |
| Bone Support INC. | $92.50 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $85.11 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $80.39 | 2023-2025 | Gemtesa |
| Biohaven Pharmaceuticals, INC. | $77.99 | 2020-2021 | |
| Next Science LLC | $71.33 | 2021 | |
| Idorsia Pharmaceuticals US INC | $60.01 | 2022-2024 | Quviviq |
| Prescient Lab Services, LLC | $58.44 | 2025 | Avertd Amplification Mix, Avertd Intellipac Reagent Module, Avertd Biofilmchip Microarray Magazine |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $55.81 | 2024-2025 | Caplyta |
| Xeris Pharmaceuticals, INC. | $51.25 | 2023-2024 | Gvoke Hypopen |
| Alexion Pharmaceuticals, INC. | $50.79 | 2021-2023 | Ultomiris |
| Acadia Pharmaceuticals INC | $49.25 | 2020-2021 | |
| Tactile Systems Technology INC | $47.26 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Almatica Pharma LLC | $44.15 | 2022 | |
| Sunovion Pharmaceuticals INC. | $28.87 | 2019 | |
| Currax Pharmaceuticals LLC | $27.26 | 2022 | |
| Antares Pharma, INC. | $26.93 | 2021-2022 | |
| Corcept Therapeutics | $26.27 | 2019 | |
| Opko Pharmaceuticals, LLC | $25.69 | 2021 | |
| Nestle Healthcare Nutrition INC. | $25.64 | 2021 | |
| Eisai INC. | $22.87 | 2020 | |
| Ibsa Pharma INC. | $18.97 | 2020 | |
| Mylan Specialty L.P. | $17.82 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.31 | 2025 | |
| Merz Pharmaceuticals, LLC | $17.10 | 2025 | Inbrija, Ampyra |
| Seqirus USA INC | $15.32 | 2025 | Fluad, Flucelvax |
| Athena Bioscience, LLC | $15.31 | 2023 | Qdolo |
| Neurelis, INC. | $12.71 | 2022 | |
| Bardy Diagnostics, INC. | $9.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.